Mutual of America Capital Management’s Amedisys AMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-16,287
Closed -$1.6M 1355
2025
Q2
$1.6M Sell
16,287
-568
-3% -$53.7K 0.02% 880
2025
Q1
$1.56M Sell
16,855
-445
-3% -$41K 0.02% 907
2024
Q4
$1.57M Sell
17,300
-337
-2% -$30.9K 0.02% 918
2024
Q3
$1.7M Sell
17,637
-1,049
-6% -$102K 0.02% 933
2024
Q2
$1.72M Sell
18,686
-759
-4% -$70.4K 0.02% 915
2024
Q1
$1.79M Sell
19,445
-721
-4% -$67.6K 0.02% 937
2023
Q4
$1.92M Sell
20,166
-1,051
-5% -$98.2K 0.02% 916
2023
Q3
$1.98M Sell
21,217
-2,455
-10% -$227K 0.02% 873
2023
Q2
$2.16M Sell
23,672
-2,471
-9% -$203K 0.02% 875
2023
Q1
$1.92M Sell
26,143
-547
-2% -$47.3K 0.02% 912
2022
Q4
$2.23M Buy
26,690
+624
+2% +$56.3K 0.03% 858
2022
Q3
$2.52M Sell
26,066
-1,166
-4% -$139K 0.03% 740
2022
Q2
$2.86M Sell
27,232
-2,497
-8% -$319K 0.04% 718
2022
Q1
$5.12M Buy
29,729
+570
+2% +$85.2K 0.05% 523
2021
Q4
$4.72M Buy
29,159
+385
+1% +$61.9K 0.05% 595
2021
Q3
$4.29M Buy
28,774
+431
+2% +$89.6K 0.04% 611
2021
Q2
$6.94M Sell
28,343
-1,391
-5% -$365K 0.07% 359
2021
Q1
$7.87M Sell
29,734
-560
-2% -$158K 0.08% 292
2020
Q4
$8.89M Sell
30,294
-88
-0.3% -$22.6K 0.1% 214
2020
Q3
$7.18M Buy
30,382
+24
+0.1% +$5.46K 0.1% 226
2020
Q2
$6.03M Buy
30,358
+360
+1% +$67.1K 0.09% 265
2020
Q1
$5.51M Buy
29,998
+985
+3% +$175K 0.09% 250
2019
Q4
$4.84M Buy
29,013
+252
+0.9% +$37.5K 0.06% 448
2019
Q3
$3.77M Buy
28,761
+3,033
+12% +$395K 0.05% 547
2019
Q2
$3.12M Buy
25,728
+66
+0.3% +$7.83K 0.04% 661
2019
Q1
$3.16M Buy
25,662
+24,936
+3,435% +$3.13M 0.05% 637
2018
Q4
$85K Buy
726
+176
+32% +$20.7K ﹤0.01% 1166
2018
Q3
$69K Buy
550
+445
+424% +$49.1K ﹤0.01% 1200
2018
Q2
$9K Buy
+105
New +$7.71K ﹤0.01% 1253

Other funds holding AMED

Mutual of America Capital Management's AMED Position: Q3 2025 in Review

Mutual of America Capital Management sold out of Amedisys (AMED) in Q3 2025, closing a stake of 16,287 shares — an estimated $1.6M sold.

Mutual of America Capital Management first reported a position in AMED in Q2 2018 and held it in 29 quarters. The position peaked at $8.89M in Q4 2020. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Mutual of America Capital Management reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Mutual of America Capital Management sold 16,287 Amedisys shares in Q3 2025, an estimated $1.6M.
  • Mutual of America Capital Management first reported a position in Amedisys in Q2 2018 and held it in 29 quarters.
  • Mutual of America Capital Management's Amedisys position peaked at $8.89M in Q4 2020.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Mutual of America Capital Management's 13F filing for Q3 2025, filed 31 Oct 2025.